Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%. (Q51345124)
Jump to navigation
Jump to search
scientific article published on 4 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%. |
scientific article published on 4 February 2013 |
Statements
1 reference
Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%. (English)
1 reference
H Maeda
1 reference
A Kubota
1 reference
A Kanamori
1 reference
Y Tanaka
1 reference
Y Terauchi
1 reference
I Matsuba
1 reference
ASSET-K Study Group
1 reference
4 February 2013
1 reference
36
1 reference
8
1 reference
568-573
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference